Coverage policies compared for back pain medications

Coverage policies compared for back pain medications

(HealthDay)—There are opportunities for recalibrating the role of opioids in pain care, including expanding access to opioid alternatives through coverage and reimbursement policies, according to a study published online June 22 in JAMA Network Open.

Dora H. Lin, M.H.S., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues examined medication coverage policies for 30 and 32 non-opioids used to treat low back pain in a study of health plan documents from 15 Medicaid, 15 Medicare Advantage, and 20 .

The researchers found that the Medicaid plans covered a median of 19 opioids and 22 non-opioids examined; Medicare Advantage plans covered 17 opioids and 22 non-opioids; and commercial plans covered 23 opioids and 26 non-opioids. Utilization management strategies were common for opioids in Medicaid plans, Medicare Advantage plans, and commercial plans (median, 15, 15, and 16, respectively) and generally relied on 30-day quantity limits instead of prior authorization. Many of the non-opioids were also subject to utilization management, especially quantity limits and prior authorization. According to informant interviews, there was an emphasis on increasing opioid utilization management and identifying high-risk prescribers and patients rather than promoting comprehensive strategies to improve .

"These findings provide an important opportunity to evaluate how formulary placement, utilization management, copayments, and integration of non-pharmacologic treatments can be optimized to improve pain care while reducing -related injuries and deaths," the authors write.

Two authors disclosed financial ties to the pharmaceutical and technology industries.

Explore further

Health insurance plans may be fueling opioid epidemic

More information: Abstract/Full Text

Copyright © 2018 HealthDay. All rights reserved.

Citation: Coverage policies compared for back pain medications (2018, June 25) retrieved 15 October 2019 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more